- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04422548
Does AI-assisted Colonoscopy Improve Adenoma Detection in Screening Colonoscopy?
Does AI-assisted Colonoscopy Improve Adenoma Detection in Screening Colonoscopy? A Multi-center Randomized Controlled
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
There are several studies showing that AI-assisted colonoscopy can help in identifying and characterizing polyps found on colonoscopy.
- Byrne et al demonstrated that their AI model for real-time assessment of endoscopic video images of colorectal polyp can differentiate between hyperplastic diminutive polyps vs adenomatous polyps with sensitivity of 98% and specificity of 83% (Byrne et al. GUT 2019)
- Urban et al designed and trained deep CNNs to detect polyps in archived video with a ROC curve of 0.991 and accuracy of 96.4%. The total number of polyps identified is significantly higher but mainly in the small (1-3mm and 4-6mm polyps) (Urban et al. Gastroenterol 2018)
- Wang et al conducted an open, non-blinded trial consecutive patients (n=1058) prospectively randomized to undergo diagnostic colonoscopy with or without AI assistance. They found that AI system increased ADR from 20.3% to 29.1% and the mean number of adenomas per patients from 0.31 to 0.53. This was due to a higher number of diminutive polyps found while there was no statistic difference in larger adenoma. (Wang et al. GUT 2019). In this study, they excluded patients with IBD, CRC and colorectal surgery. The patients presented with symptoms to hospital for investigation.
To date, there is a lack of large-scale randomized controlled study using AI assistance in the detection of polyps/adenoma in a screening population. The correlation of fecal occult blood test (FIT or FOBT) and the advantage of AI-assisted colonoscopy has not been investigated. There is also a lack of information of the benefit of AI-assisted colonoscopy in experienced colonoscopist versus trainee/resident.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Hong Kong, Hong Kong
- Recruiting
- Prince of Wales Hospital
-
Contact:
- Ming Yeung HO
- Phone Number: 26371398
- Email: andrewho@cuhk.edu.hk
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria
- Patients receiving colonoscopy screening
- Patients aged 45-75 years
- Both patients who have or have not done a FIT test and both FIT +ve and FIT -ve subjects
Exclusion Criteria
- Patients who have symptom(s) suggestive of colorectal diseases
- Patients who have a history of inflammatory bowel disease, colorectal cancer or polyposis syndrome (anaemia, bloody stool, tenesmus and obstructive symptoms)
- Patients who had colonoscopy or other investigation of colon and rectum in the past 10 years
- Patients who had surgery for colorectal diseases
- Patients who cannot tolerate bowel preparation or have suboptimal bowel preparations (Boston Bowel Preparation Scale)
- Cannot reach caecum
- Patients who are incompetent in giving informed consent
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Standard
|
Standard Colonoscopy
|
Active Comparator: AI-assisted Group
|
This is a multi-center prospective randomized controlled study comparing real-time AI-assisted colonoscopy versus standard colonoscopy in a real-life setting.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Per-patient ADR in each group
Time Frame: 12 months
|
For the AI-Assisted group, it is defined as the number of patients with at least 1 adenoma identified in the colon divided by the total number of patients in the AI-Assisted group.
|
12 months
|
Per-patient ADR in each group
Time Frame: 12 months
|
For the Standard group, it is defined as the number of patients with at least 1 adenoma identified in the colon divided by the total number of patients in the Standard group.
|
12 months
|
Collaborators and Investigators
Sponsor
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- AI-CLN Study_Protocol
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Screening Colonoscopy
-
Borland-Groover ClinicValley Medical Products, LLC is paying for the study and is the sponsor....CompletedColonoscopy | Screening Colonoscopy | Surveillance ColonoscopyUnited States
-
HyGIeaCare, Inc.MedtronicCompletedScreening ColonoscopyUnited States
-
University of Colorado, DenverThe Henry J. Kaiser Family FoundationCompletedColonoscopy | Mass ScreeningUnited States
-
Konkuk University Medical CenterGlaxoSmithKlineCompletedDiagnostic Colonoscopy ScreeningKorea, Republic of
-
GI View Ltd.Terminated
-
Medical College of WisconsinWithdrawnPatients Undergoing Screening or Surveillance ColonoscopyUnited States
-
Magentiq Eye LTDCompletedScreening Colonoscopy | Surveillance ColonoscopyUnited States, Israel, Germany, Netherlands
-
NYU Langone HealthCompleted
-
Sheffield Teaching Hospitals NHS Foundation TrustCompletedAnalgesia | Colonoscopy | Bowel Cancer Screening | EntonoxUnited Kingdom
-
Chinese University of Hong KongCompletedScreening ColonoscopyHong Kong
Clinical Trials on Standard Colonoscopy
-
Dr. Horst Schmidt Klinik GmbHCompletedAdenoma | Colo-rectal CancerGermany
-
The University of Texas Health Science Center,...WithdrawnColorectal NeoplasmsUnited States
-
The Catholic University of KoreaUnknown
-
Northwestern UniversityTerminated
-
Chinese University of Hong KongCompletedFirst Colonoscopy ExaminationChina
-
University of NaplesCompletedAdenomatous PolypsItaly
-
Portsmouth Hospitals NHS TrustUniversity of PortsmouthCompletedIntestinal Neoplasms | Digestive System Disease | Gastrointestinal Disease | Colorectal Neoplasia | Intestinal Disease | Gastrointestinal Neoplasm | Digestive NeoplasmsUnited Kingdom
-
Smart Medical Systems Ltd.CompletedColorectal Cancer | AdenomaGermany
-
Smart Medical Systems Ltd.CompletedColorectal Cancer | Adenoma | PolypsUnited States, Netherlands, Israel, United Kingdom, India, Germany, Denmark, Italy
-
Smart Medical Systems Ltd.UnknownColorectal Cancer | Adenoma | PolypsIsrael